Viewing Study NCT06615921



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06615921
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-08-23

Brief Title: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus CMV Infection
Sponsor: None
Organization: None

Study Overview

Official Title: A Multi-country Multi-center Retrospective Chart Review to Describe the Use of Maribavir and Its Effectiveness in Patients With Post-Transplant Cytomegalovirus InfectionDisease
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main aim of this study is to check how effective the treatment with Maribavir has been to remove the CMV viruses from the blood of an adult person with CMV infection after a transplant Other aims are to learn more about how maribavir is used in normal clinical routine study the profiles of adults treated with maribavir and what other treatments have been given and describe healthcare resources used for CMV management

Only data already available in the medical records of the participants will be reviewed and collected during this study
Detailed Description: This study will include two main periods of retrospective data collection from medical charts the pre-index period and the post-index period The index date is defined as the date of initiation of maribavir dosing as documented in the medical records The pre-index period covers the time from the transplant date to the index event while the post-index period starts at the index event and ends at the date of chart abstraction death or loss to follow-up whichever comes first

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None